Jasper Ridge Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Hold |
39,457
| – | – | 0.01% | 106 |
|
|
2025
Q1 | $344K | Hold |
39,457
| – | – | 0.01% | 112 |
|
|
2024
Q4 | $567K | Hold |
39,457
| – | – | 0.02% | 99 |
|
|
2024
Q3 | $891K | Hold |
39,457
| – | – | 0.03% | 92 |
|
|
2024
Q2 | $767K | Hold |
39,457
| – | – | 0.02% | 96 |
|
|
2024
Q1 | $1.48M | Hold |
39,457
| – | – | 0.05% | 85 |
|
|
2023
Q4 | $2.21M | Hold |
39,457
| – | – | 0.09% | 65 |
|
|
2023
Q3 | $1.63M | Buy |
39,457
+3,206
| +9% | +$132K | 0.08% | 70 |
|
|
2023
Q2 | $2.02M | Sell |
36,251
-8,533
| -19% | -$476K | 0.1% | 63 |
|
|
2023
Q1 | $2.5M | Buy |
44,784
+12,426
| +38% | +$693K | 0.12% | 56 |
|
|
2022
Q4 | $1.18M | Hold |
32,358
| – | – | 0.07% | 70 |
|
|
2022
Q3 | $922K | Hold |
32,358
| – | – | 0.06% | 84 |
|
|
2022
Q2 | $1.46M | Buy |
32,358
+3,435
| +12% | +$155K | 0.09% | 72 |
|
|
2022
Q1 | $2.2M | Buy |
28,923
+3,294
| +13% | +$251K | 0.11% | 71 |
|
|
2021
Q4 | $3.82M | Buy |
25,629
+2,196
| +9% | +$327K | 0.14% | 61 |
|
|
2021
Q3 | $3.41M | Hold |
23,433
| – | – | 0.15% | 65 |
|
|
2021
Q2 | $4.59M | Buy |
23,433
+2,544
| +12% | +$498K | 0.23% | 53 |
|
|
2021
Q1 | $3.78M | Buy |
20,889
+6,956
| +50% | +$1.26M | 0.17% | 50 |
|
|
2020
Q4 | $1.97M | Buy |
13,933
+200
| +1% | +$28.3K | 0.09% | 63 |
|
|
2020
Q3 | $1.71M | Buy |
13,733
+6,289
| +84% | +$784K | 0.1% | 59 |
|
|
2020
Q2 | $665K | Buy |
+7,444
| New | +$665K | 0.05% | 77 |
|